ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2023

IgG4-Related Midline Destructive Lesion: Expanding The Spectrum Of Organ Involvement In IgG4-Related Disease

Emanuel Della Torre1, Donald Krause2, Vikram Deshpande3, Vinay Mahajan4, Hamid Mattoo5, Shiv Pillai6 and John Stone7, 1Cancer Center, Massachusetts General Hospital, Boston, MA, 2Medicine, St. Joseph's Hospital, Bangor, ME, 3Pathology, Massachusetts General Hospital, Boston, MA, 4Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 6Oncology, Massachusetts General Hospital, Boston, MA, 7Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: IgG4 Related Disease and Plasmablasts

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases II: Miscellaneous Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Midline destructive lesion (MDL) is a fibroinflammatory condition involving the nose, paranasal sinuses, and palate with relentless erosion through contiguous facial structures.  A variety of historical terms, including “lethal midline granuloma”, have been used to describe MDL.  The characteristic lesion is an ulcerative process that occurs in the nose and palate associated with epithelium and cartilage loss, leadingultimately to functional deformity. MDL may occur in a variety of inflammatory, neoplastic, and infectious disorders, but the diagnosis remains elusive in a significant proportion of idiopathic cases.We report three patients with MDLwhose cases were marked by clinical, serological, and histopathological features diagnostic of IgG4-related disease (IgG4-RD).

Methods:

We evaluated three patients with MDL involving the soft palate and uvula.  Two patients also had nasal septal perforations.  We investigated the clinical and radiological features of each case, performed flow cytometry on peripheral blood to determine the concentration of IgG4+ plasmablasts, and reviewed the histopathology, performing immunostaining for IgG and IgG4.

Results:

The three patients, one man and two women, were aged 54, 38, and 27, respectively.  All three patients were heavy, current tobacco smokers.  One patient had a remote history of intranasal cocaine use but had not used cocaine for six years before the onset of her palatal and nasal symptoms.Onset of symptoms was subacutein all patients and, in view of the extent of the tissue destruction, the lesions appeared (in retrospect) to have occurred with remarkably little symptomatology.  The processes began as small ulcers in the soft palate that evolved slowly into palatal perforations.  The onset and progression of nasal septal perforation was equally subacute and subclinical. 

Two patients had obtained prostheses to plug their soft palate defects, facilitate speech, and prevent nasal regurgitation of liquids and food.  The third patient had remnants of food within her nasal cavity.  Physical examination demonstrated a hypernasalspeechquality and florid palatal and nasal septal lesions.  The uvulae were absent in all three cases.  There were no obvious sites of disease beyond the soft palate and nasal cavity, but diagnostic imaging is awaited presently in one patient.  Infections, malignancies, and autoimmune disorders were excluded by extensive serological, microbiological, and histopathological examinations. 

The serum IgG4 concentrations were normal in all three patients (96, 119, and 11 mg/dL, respectively; normal < 121 mg/dL)(the third patient had been treated with rituximab).  However, all three patients had substantial elevations of IgG4+ plasmablastin blood, with concentrations of 85,200/ml, 3835/ml, and 7351/ml, respectively (normal < 300/ml).  Pathologyin all three cases showedtypical histopathological features of IgG4-RD: a diffuse lymphoplasmacytic infiltratewith an abundance of IgG4-positive plasma cells, a mild to moderate tissue eosinophilia, storiform fibrosis, and obliterative phlebitis.

Conclusion:

IgG4-RD is a cause of midline destructive lesions involving the soft palate, uvula, and nasal septum.


Disclosure:

E. Della Torre,
None;

D. Krause,
None;

V. Deshpande,
None;

V. Mahajan,
None;

H. Mattoo,
None;

S. Pillai,
None;

J. Stone,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/igg4-related-midline-destructive-lesion-expanding-the-spectrum-of-organ-involvement-in-igg4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology